- Home
- BZFD vs CTMX Comparison
BZFD vs CTMX Comparison
Compare BZFD & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BZFD
- CTMX
- Stock Information
- Founded
- BZFD 2006
- CTMX 2008
- Country
- BZFD United States
- CTMX United States
- Employees
- BZFD N/A
- CTMX N/A
- Industry
- BZFD Movies/Entertainment
- CTMX Biotechnology: Pharmaceutical Preparations
- Sector
- BZFD Consumer Discretionary
- CTMX Health Care
- Exchange
- BZFD Nasdaq
- CTMX Nasdaq
- Market Cap
- BZFD 76.7M
- CTMX 60.7M
- IPO Year
- BZFD N/A
- CTMX 2015
- Fundamental
- Price
- BZFD $2.15
- CTMX $2.65
- Analyst Decision
- BZFD
- CTMX Strong Buy
- Analyst Count
- BZFD 0
- CTMX 2
- Target Price
- BZFD N/A
- CTMX $5.00
- AVG Volume (30 Days)
- BZFD 413.9K
- CTMX 11.5M
- Earning Date
- BZFD 05-07-2025
- CTMX 05-12-2025
- Dividend Yield
- BZFD N/A
- CTMX N/A
- EPS Growth
- BZFD N/A
- CTMX 128.27
- EPS
- BZFD 0.34
- CTMX 0.49
- Revenue
- BZFD $188,899,000.00
- CTMX $147,557,000.00
- Revenue This Year
- BZFD $89.62
- CTMX N/A
- Revenue Next Year
- BZFD $4.50
- CTMX N/A
- P/E Ratio
- BZFD $6.39
- CTMX $5.46
- Revenue Growth
- BZFD N/A
- CTMX 23.81
- 52 Week Low
- BZFD $1.61
- CTMX $0.40
- 52 Week High
- BZFD $5.68
- CTMX $2.71
- Technical
- Relative Strength Index (RSI)
- BZFD 54.79
- CTMX 75.39
- Support Level
- BZFD $1.91
- CTMX $1.97
- Resistance Level
- BZFD $2.50
- CTMX $2.64
- Average True Range (ATR)
- BZFD 0.17
- CTMX 0.33
- MACD
- BZFD 0.03
- CTMX 0.04
- Stochastic Oscillator
- BZFD 49.28
- CTMX 94.34
About BZFD BuzzFeed Inc.
BuzzFeed Inc is a tech-powered, diversified media company that reaches hundreds of millions globally through its cross-platform news and entertainment network. The company produces articles, lists, quizzes, videos, and original series; lifestyle content through brands including Tasty, social food network; original reporting and investigative journalism through BuzzFeed News and HuffPost; an industry- affiliate business, strategic partnerships, licensing and product development through BuzzFeed Commerce; and original productions across broadcast, cable, SVOD, film and digital platforms for BuzzFeed Studios.
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.